Your browser doesn't support javascript.
loading
Impact of ABCB1 1236C > T-2677G > T-3435C > T polymorphisms on the anti-proliferative activity of imatinib, nilotinib, dasatinib and ponatinib.
Dessilly, Géraldine; Panin, Nadtha; Elens, Laure; Haufroid, Vincent; Demoulin, Jean-Baptiste.
Afiliação
  • Dessilly G; Louvain centre for Toxicology and Applied Pharmacology, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Brussels, Belgium.
  • Panin N; Louvain centre for Toxicology and Applied Pharmacology, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Brussels, Belgium.
  • Elens L; Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium.
  • Haufroid V; Louvain centre for Toxicology and Applied Pharmacology, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Brussels, Belgium.
  • Demoulin JB; Department of Clinical Chemistry, Cliniques Universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium.
Sci Rep ; 6: 29559, 2016 07 12.
Article em En | MEDLINE | ID: mdl-27405085

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piridazinas / Pirimidinas / Inibidores de Proteínas Quinases / Proliferação de Células / Mesilato de Imatinib / Dasatinibe / Imidazóis / Antineoplásicos Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piridazinas / Pirimidinas / Inibidores de Proteínas Quinases / Proliferação de Células / Mesilato de Imatinib / Dasatinibe / Imidazóis / Antineoplásicos Idioma: En Ano de publicação: 2016 Tipo de documento: Article